im guessing FDA will call for labels to be put on the product warning about the risks until they gather more long term data , will it hurt sales in the long run . Regardless i think it will go back up after initial reaction.
ACR Price at posting:
$1.04 Sentiment: Hold Disclosure: Not Held
